RedHill Biopharma (RDHL) Inventory Average (2017 - 2025)
Historic Inventory Average for RedHill Biopharma (RDHL) over the last 9 years, with Q2 2025 value amounting to $3.4 million.
- RedHill Biopharma's Inventory Average fell 1675.82% to $3.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.4 million, marking a year-over-year decrease of 1675.82%. This contributed to the annual value of $4.0 million for FY2024, which is 4778.54% down from last year.
- Per RedHill Biopharma's latest filing, its Inventory Average stood at $3.4 million for Q2 2025, which was down 1675.82% from $3.7 million recorded in Q4 2024.
- RedHill Biopharma's 5-year Inventory Average high stood at $13.0 million for Q2 2022, and its period low was $3.4 million during Q2 2025.
- Its 5-year average for Inventory Average is $8.3 million, with a median of $8.7 million in 2021.
- Per our database at Business Quant, RedHill Biopharma's Inventory Average surged by 23977.2% in 2021 and then plummeted by 6046.28% in 2023.
- RedHill Biopharma's Inventory Average (Quarter) stood at $10.4 million in 2021, then increased by 13.35% to $11.8 million in 2022, then plummeted by 60.46% to $4.7 million in 2023, then fell by 20.08% to $3.7 million in 2024, then decreased by 8.52% to $3.4 million in 2025.
- Its Inventory Average stands at $3.4 million for Q2 2025, versus $3.7 million for Q4 2024 and $4.1 million for Q2 2024.